TAT Technologies (TATT) manager reports detailed stock option grants

Rhea-AI Filing Summary

TAT Technologies Ltd executive Topaz Liron filed an initial ownership report showing stock option holdings, but no recent buy or sell transactions. Liron holds options over 12,500 Ordinary Shares at an exercise price of $6.42 per share, expiring on May 1, 2029. Of these, 11,250 options are vested and outstanding, and 1,250 are scheduled to vest on May 1, 2026, subject to continued employment.

Liron also holds options over 30,000 Ordinary Shares at an exercise price of $29.93 per share, expiring on February 4, 2032. For this grant, 7,500 options vest on February 4, 2026, with 1,875 options vesting every three months thereafter through February 4, 2029. The filing shows no Ordinary Shares held directly.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Topaz Liron

(Last) (First) (Middle)

9335 HARRIS UNIT 260

CORNERS PKWY

(Street)

CHARLOTTE NORTH CAROLINA 28269

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TAT TECHNOLOGIES LTD [ TATT ]

3a. Foreign Trading Symbol
[TATT]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			TAT Israel General Manager

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(1)	05/01/2029	Ordinary Shares	12,500	$6.42	D
Stock Options (right to buy)	(2)	02/04/2032	Ordinary Shares	30,000	$29.93	D

Explanation of Responses:

1. 20,000 Stock options were granted on May 1, 2022. 7,500 of such options were previously vested, exercised and the underlying shares were sold. Of the 12,500 remaining options, 11,250 options are vested and outstanding and 1,250 options will vest on May 1, 2026, subject to the Reporting Person's continued employment with the Issuer through each such vesting date.

2. Stock options were granted on February 4, 2025 with 7,500 vesting on February 4,2026 and 1,875 vesting at each three months after February 4,2026 through February 4, 2029.

	/s/ Liron Topaz	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Topaz Liron report owning in TAT Technologies (TATT)?

Topaz Liron reports stock options, not direct shares, in TAT Technologies. The filing shows options over 12,500 Ordinary Shares at $6.42 and 30,000 Ordinary Shares at $29.93, with different vesting schedules and expirations extending to 2032.

Are there any recent insider share purchases or sales in this TATT Form 3?

The Form 3 shows no recent purchases or sales of TAT Technologies shares by Topaz Liron. It is an initial ownership report listing existing stock option positions and their vesting terms, rather than documenting new market transactions in Ordinary Shares.

What are the key terms of Topaz Liron’s 2022 stock option grant at TATT?

The 2022 grant covers 20,000 stock options at $6.42 per share. Footnotes state 7,500 options were already vested, exercised, and sold; 12,500 remain, with 11,250 vested and 1,250 scheduled to vest on May 1, 2026, subject to continued employment.

How do the 2025 stock options for Topaz Liron at TAT Technologies vest?

The 2025 options cover 30,000 Ordinary Shares at an exercise price of $29.93. Vesting occurs with 7,500 options on February 4, 2026, then 1,875 options vesting every three months from that date through February 4, 2029, according to the footnote.

Does Topaz Liron directly hold any TAT Technologies Ordinary Shares?

The Form 3 shows zero Ordinary Shares directly held by Topaz Liron after the reported positions. The only reported interests are stock options over 12,500 shares at $6.42 and 30,000 shares at $29.93, each with specified vesting and expiration dates.